BlackRock’s Unity Biotechnology UBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$31.3K Hold
81,402
﹤0.01% 5001
2025
Q1
$84.7K Hold
81,402
﹤0.01% 4762
2024
Q4
$79.5K Buy
81,402
+228
+0.3% +$223 ﹤0.01% 4782
2024
Q3
$119K Sell
81,174
-7,211
-8% -$10.6K ﹤0.01% 4592
2024
Q2
$119K Sell
88,385
-23,944
-21% -$32.3K ﹤0.01% 4613
2024
Q1
$184K Sell
112,329
-752
-0.7% -$1.23K ﹤0.01% 4541
2023
Q4
$218K Sell
113,081
-376
-0.3% -$726 ﹤0.01% 4544
2023
Q3
$272K Sell
113,457
-1,389
-1% -$3.33K ﹤0.01% 4523
2023
Q2
$293K Buy
114,846
+7,350
+7% +$18.7K ﹤0.01% 4545
2023
Q1
$175K Buy
107,496
+37,078
+53% +$60.4K ﹤0.01% 4731
2022
Q4
$193K Buy
70,418
+14,069
+25% +$38.5K ﹤0.01% 4780
2022
Q3
$223K Sell
56,349
-1,682
-3% -$6.66K ﹤0.01% 4862
2022
Q2
$327K Buy
58,031
+996
+2% +$5.61K ﹤0.01% 4810
2022
Q1
$638K Sell
57,035
-517
-0.9% -$5.78K ﹤0.01% 4723
2021
Q4
$840K Sell
57,552
-32,511
-36% -$475K ﹤0.01% 4653
2021
Q3
$2.7M Buy
90,063
+1,806
+2% +$54.2K ﹤0.01% 4128
2021
Q2
$4.09M Sell
88,257
-196,155
-69% -$9.1M ﹤0.01% 3900
2021
Q1
$17.1M Sell
284,412
-3,753
-1% -$225K ﹤0.01% 3208
2020
Q4
$15.1M Buy
288,165
+17,902
+7% +$938K ﹤0.01% 3090
2020
Q3
$9.35M Sell
270,263
-18,972
-7% -$656K ﹤0.01% 3177
2020
Q2
$25.1M Buy
289,235
+68,434
+31% +$5.94M ﹤0.01% 2640
2020
Q1
$12.8M Sell
220,801
-132
-0.1% -$7.66K ﹤0.01% 2816
2019
Q4
$15.9M Buy
220,933
+14,661
+7% +$1.06M ﹤0.01% 2972
2019
Q3
$12.6M Buy
206,272
+7,011
+4% +$428K ﹤0.01% 3068
2019
Q2
$18.9M Buy
199,261
+9,418
+5% +$895K ﹤0.01% 2841
2019
Q1
$15.4M Buy
189,843
+4,755
+3% +$386K ﹤0.01% 2866
2018
Q4
$30.1M Buy
185,088
+150,891
+441% +$24.5M ﹤0.01% 2499
2018
Q3
$5.57M Buy
34,197
+11,103
+48% +$1.81M ﹤0.01% 3439
2018
Q2
$3.48M Buy
+23,094
New +$3.48M ﹤0.01% 3537